Levels of phenolic acids, catechin and epicatechin in wines of Portugal and the Azores produced from different varieties and vintages;Teneurs en acides phénols, catéchine et épicaté chine pour les vins de différentes variétés et millésimes du Portugal continental et des îles des Açores

Journal International des Sciences de la Vigne et du Vin

Volumn 40, Issue 1, 2006, Pages 47-56

  Ribeiro De Lima, Maria Teresa ^a   Kelly, Mary T ^b   Cabanis, Marie T ^b   Blaise, A ^b  

^a UNIVERSITY OF THE AZORES   (Portugal)

^b UNIV MONTPELLIER   (France)

Author keywords

Cardiovascular disease; Catechin; Epicatechin; HPLC; LDL; Lipoxygenation; Phenolic acids; Wine

Indexed keywords

EID: 33845794302     PISSN: 11510285     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. AL-AWWADI N., BORNET A., AZAY J., ARAIZ C., SANDRINE DELBOSC S., CRISTOL J-P., LINCK N., CROS G. and TEISSEDRE P.L., 2004. Red wine polyphenols alone or in association with ethanol prevent hypertension, cardiac hypertrophy, and production of reactive oxygen species in the insulin-resistant fructose-fed rat. J. Agric. Food Chem., 52, 5593-5597.
2. AUGER C., B. CAPORICCIO, N. LANDRAULT, P. L. TEISSEDRE, C. LAURENT, G. CROS, P. BESANCON, J.M. ROUANET, 2002. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B, and prevent early aortic atherosclerosis in hypercholesterolemic Golden Syrian Hamsters (Mesocrincetus auratus). Journal Nutrition, 132, 1207-1213.
3. AVIRAM M. and FUHRMA B., 1998. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis, 137, S45-S50.
4. BELL J.R.C., DONOVAN J.L., WONG R., WATERHOUSE A.L., GERMAN J.B., WALZEM R.L., KASIM-KARAKAS S.E. (2000). (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am. J. Clinical Nutrition, 71, 103-108,
5. BETES-SAURA C., ANDRES-LACUEVA C. and LAMUELA-RAVENTOS R.M., 1996. Phenolics in white free run juices and wines from Penedès by high-performance liquid chromatography: Changes during vinification. J. Agr. Food Chem., 44, 3040-3046.
6. CARANDO S, TEISSEDRE P.L., CABANIS. J.C., 1998. Comparison of (+)-catechin determination in human plasma by high-performance liquid chromatography with two types of detection: fluorescence and ultraviolet. J. Chromatogr. B, 707, 195-201.
7. CLEOPHAS T.J., 1999. Wine, beer and spirits and the risk of myocardial infarction: a systematic review. Biomedecine & Pharmacotherapy, 53, 417-423.
8. DELL'AGLI M., BUSCIALA A. and BOSISIO E., 2004. Vascular effects of wine polyphenols. Cardiovascular Res., 63, 593-602.
9. ESTERBAUER H, DIEBER-ROTHENEDER M, WAEG G., STRIEGL G. and JURGENS G., 1990. Biochemical structural and functional properties of oxidized LDL. Chem. Res. Toxicol., 3, 77-92.
10. FRANKEL E.N., WATERHOUSE A.L. and TEISSEDRE P.L., 1995. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoprotein. J. Agric. Food Chemistry, 43, 890-894.
11. FU W., CONKLIN B. S., LIN P. H., LUMSDEN A. B., YAO Q. and CHEN C., 2003. Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries. J. Surgic. Res., 115, 82-91.
12. GOLDBERG D.M., YAN J., NG.E., KARUMANCHIRI A., SOLEAS G. and WATERHOUSE A.L., 1995. A global survey of trans-resveratrol concentrations in commercial wwines. Am. J. Enol. Vitic., 46, 159-165.
13. GOLDBERG D.M., YAN J. and SOLEAS G. J., 2003. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry, 36, 79-87.
14. GRØNBÆK M., 2004. Epidemiologic evidence for the cardioprotective effects associated with consumption of alcoholic beverages. Pathophysiology, 10, 83-92.
15. LAMUELA-RAVENTOS R.M. and WATERHOUSE A.L., 1994. A direct HPLC separation of wine phenolics. Am. J. Enol. Vitic., 45, 1-5.
16. LEGER C.L., CARBONNEAU M.A., CARTRON E., MONNIER L. and DESCOMPS B., 2000. Implication possible des composés phénoliques du vin dans la prévention de l'athérogenèse: la nouvelle étude ex vivo de Montpellier. XXVe Congrès mondial de la vigne et du vin, Paris. Vin et Santé, 51-56.
17. MANACH C., WILLIAMSON G., MORAND C., SCALBERT A. and REMESY C., 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Amer. J. Clinical Nutrition, 81, 230S-242S.
18. MANN L.B. and FOLTS J.D., 2004. Effects of ethanol and other constituents of alcoholic beverages on coronary heart disease: a review. Pathophysiology, 10, 105-112.
19. MIYAGI K. and INOUE H., 1997. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am. J. Cardiol., 80, 1627-1631.
20. NAGEL C.W. and WULF L.W., 1979. Changes in the Anthocyanins, flavonoids and hydroxycinnamic acid esters during fermentation and ageing of Merlot and Cabemet-Sauvignon. Am. J. Enol. Vitic, 30, 111-116.
21. NIGDIKAR S., WILLIAMS N.R, GRIFFIN B.A., HOWARD A.N., 1998. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation. Am. J. Clin. Nutr., 68, 258-265.
22. RENAUD S. and DE LORGERIL M., 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet, 339, 1523-1526.
23. RIGAUD J., CHEYNIER V., SOUQUET J.M., MOUTONNET M., 1990. Mécanismes d'oxydation des polyphénols dans les moûts blancs. Rev. Franc. Œnol., 124, 27-31.
24. SATO M., FRAGA C., DA D.K., 2004. Induction of the expression of cardioprotective proteins after mild-to-moderate consumption of alcohol. Pathophysiology, 10, 139-145.
25. SUN A.Y., SIMONYI A., SUN, G.Y., 2002. The French paradox and beyond: neuroprotective effects of polyphenolsl, 2, Free Radical Biology Medicine, 32, 314-318.
26. TEISSEDRE P.L., FRANKEL E.N. and WATERHOUSE A. L.; PELEG, H.; GERMAN, J. B., 1996b. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J. Sci. Food Agric., 70, 55-61.
27. TEISSEDRE P-L. and LANDRAULT N. 2000. Wine phenolics: contribution to dietary intake and bioavailability. Food Res. Int., 33, 461-467.
28. TOMERA J.F., 1999. Current knowledge of the health benefits and disadvantages of wine consumption, Trends in Food Science & Technology, 10, 29-138.
29. TSANG C., AUGER C., MULLEN W., BORNET A., ROUANET J.M., CROZIER A. and TEISSEDRE P.L., 2005. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Brit. J. Nutrition, 9, 170-181.
30. WATERHOUSE A.L. and TEISSEDRE P.L., 1997. Levels of phenolics in California varietal wines, in ACS Symposium, Series 661, Wine, Nutritions and Therapeutic Benefits. Edited by Tom. Watkins, 12-23.